Literature DB >> 14512436

Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes.

Lisa A Cassis1, Victoria L English, Kalyani Bharadwaj, Carine M Boustany.   

Abstract

Adipocytes secrete a variety of factors, including angiotensinogen, the only known precursor to Angiotensin II (AngII). Recent studies suggest that adipocyte-derived angiotensinogen can contribute to circulating angiotensinogen concentrations and modulate blood pressure; however, an autocrine role for adipocyte-derived angiotensinogen and/or AngII has not been well defined. We sought to determine whether locally produced AngII influences the release of leptin from adipocytes and thus circulating leptin concentrations. In adipocytes from rats treated for 3 d with captopril demonstrating reductions in AngII release, leptin release and plasma leptin concentration were decreased. Incubation of adipocytes with AngII resulted in an increase in leptin mRNA expression and leptin release. To determine the effect of elevated systemic AngII on leptin, rats were infused with AngII (175 ng/kg.min) or saline for 1, 2, or 7 d. Plasma leptin concentration progressively declined with duration of AngII exposure. Basal and AngII-stimulated release of leptin from isolated adipocytes was initially (d 1) increased in AngII-infused rats; thereafter leptin release declined to levels less than control. To define mechanisms for declines in leptin in AngII-infused rats, we examined the effect of alpha-methyl-p-tyrosine on catecholamine turnover and plasma leptin concentration in saline- and AngII (175 ng/kg.min)-infused rats. Infusion of AngII increased catecholamine turnover in adipose tissue. Moreover, sympathetic blockade eliminated differences in plasma leptin concentration between saline- and AngII-infused rats. These results indicate that locally produced AngII directly increases leptin release from adipocytes; however, with elevations in systemic AngII, sympathetic activation counterbalances effects from locally produced AngII.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512436     DOI: 10.1210/en.2003-0767

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

Review 1.  Leptin and cardiovascular disease: response to therapeutic interventions.

Authors:  Kwang Kon Koh; Sang Min Park; Michael J Quon
Journal:  Circulation       Date:  2008-06-24       Impact factor: 29.690

Review 2.  The renin angiotensin system and the metabolic syndrome.

Authors:  Annette D de Kloet; Eric G Krause; Stephen C Woods
Journal:  Physiol Behav       Date:  2010-04-08

3.  Silent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease.

Authors:  Ruba S Deeb; Brian D Lamon; David P Hajjar
Journal:  Curr Hypertens Rev       Date:  2009-11-01

4.  Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma.

Authors:  Stefan Zorad; Jing-tao Dou; Julius Benicky; Daniel Hutanu; Katarina Tybitanclova; Jin Zhou; Juan M Saavedra
Journal:  Eur J Pharmacol       Date:  2006-09-09       Impact factor: 4.432

5.  A brain leptin-renin angiotensin system interaction in the regulation of sympathetic nerve activity.

Authors:  Aline M Hilzendeger; Donald A Morgan; Leonard Brooks; David Dellsperger; Xuebo Liu; Justin L Grobe; Kamal Rahmouni; Curt D Sigmund; Allyn L Mark
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-18       Impact factor: 4.733

Review 6.  Leptin and mechanisms of endothelial dysfunction and cardiovascular disease.

Authors:  Jarrod D Knudson; Gregory A Payne; Léna Borbouse; Johnathan D Tune
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 7.  Brain renin-angiotensin system in the nexus of hypertension and aging.

Authors:  Amy C Arnold; Patricia E Gallagher; Debra I Diz
Journal:  Hypertens Res       Date:  2012-10-18       Impact factor: 3.872

8.  Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity.

Authors:  Paula Stucchi; Victoria Cano; Mariano Ruiz-Gayo; María S Fernández-Alfonso
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

9.  Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.

Authors:  Helge Müller-Fielitz; Nils Hübel; Martin Mildner; Florian M Vogt; Jörg Barkhausen; Walter Raasch
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

10.  To Sensitize or Not to Sensitize: Leptin Is the Question.

Authors:  Amy C Arnold
Journal:  Hypertension       Date:  2016-03-28       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.